PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE